What is it about?
Chronic Obstructive Pulmonary Disease (COPD) is characterized by systemic involvement and multiple comorbidities. The incidence of these comorbidities increases later in life, decreasing the quality of life of patients with COPD, as well as complicating the management of the disease.
Featured Image
Why is it important?
Our article is an up-to-date review of the prevalence and disease burden of the comorbidities that are often associated with COPD, as well as their interaction with, and impact on, COPD exacerbations.
Perspectives
The most frequently described comorbidities of COPD include skeletal muscle wasting, cachexia (loss of fat-free mass), lung cancer (small cell or non-small cell), pulmonary hypertension, ischemic heart disease, hyperlipidemia, congestive heart failure, normocytic anemia, diabetes, metabolic syndrome, osteoporosis, obstructive sleep apnea, depression, and arthritis.
Professor Alexandru Corlateanu
State University of Medicine and Pharmacy "Nicolae Testemitanu"
Read the Original
This page is a summary of: Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease, Respiratory Investigation, November 2016, Elsevier,
DOI: 10.1016/j.resinv.2016.07.001.
You can read the full text:
Contributors
The following have contributed to this page
